Business | Tuesday February 12, 2013
Dr Reddy's Laboratories (DRL), which is in the process of acquiring Netherlands-based specialty pharmaceutical company OctoPlus NV for about 27.4 million euro, has so far managed to get nearly 93 per cent shares of the firm in its favour.
www.ndtv.com/business